Hemenway Trust Co LLC Has $24.66 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Hemenway Trust Co LLC lifted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 4.5% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 49,857 shares of the healthcare conglomerate’s stock after purchasing an additional 2,136 shares during the quarter. UnitedHealth Group accounts for approximately 2.1% of Hemenway Trust Co LLC’s investment portfolio, making the stock its 23rd biggest holding. Hemenway Trust Co LLC’s holdings in UnitedHealth Group were worth $24,664,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. Tealwood Asset Management Inc. lifted its position in shares of UnitedHealth Group by 0.4% in the fourth quarter. Tealwood Asset Management Inc. now owns 4,988 shares of the healthcare conglomerate’s stock worth $2,626,000 after purchasing an additional 19 shares in the last quarter. Atlas Private Wealth Advisors raised its position in UnitedHealth Group by 1.1% during the fourth quarter. Atlas Private Wealth Advisors now owns 1,752 shares of the healthcare conglomerate’s stock worth $923,000 after acquiring an additional 19 shares in the last quarter. Prentice Wealth Management LLC raised its position in UnitedHealth Group by 0.8% during the fourth quarter. Prentice Wealth Management LLC now owns 2,347 shares of the healthcare conglomerate’s stock worth $1,235,000 after acquiring an additional 19 shares in the last quarter. Veery Capital LLC raised its position in UnitedHealth Group by 2.5% during the fourth quarter. Veery Capital LLC now owns 812 shares of the healthcare conglomerate’s stock worth $427,000 after acquiring an additional 20 shares in the last quarter. Finally, Sunflower Bank N.A. raised its position in UnitedHealth Group by 1.4% during the fourth quarter. Sunflower Bank N.A. now owns 1,478 shares of the healthcare conglomerate’s stock worth $778,000 after acquiring an additional 20 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH stock traded up $3.35 on Thursday, reaching $504.28. The company had a trading volume of 3,535,102 shares, compared to its average volume of 4,241,919. The stock has a market capitalization of $464.13 billion, a PE ratio of 30.82, a price-to-earnings-growth ratio of 1.44 and a beta of 0.60. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The business’s 50-day moving average is $499.20 and its 200 day moving average is $500.05.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. The firm had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business’s revenue for the quarter was up 8.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.26 earnings per share. Equities research analysts forecast that UnitedHealth Group Incorporated will post 27.55 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Investors of record on Monday, June 17th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.67%. The ex-dividend date of this dividend was Monday, June 17th. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.88. UnitedHealth Group’s dividend payout ratio (DPR) is 51.34%.

Wall Street Analysts Forecast Growth

Several brokerages have recently weighed in on UNH. Royal Bank of Canada dropped their price objective on shares of UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 17th. Baird R W raised shares of UnitedHealth Group to a “strong-buy” rating in a research report on Thursday, May 30th. Morgan Stanley decreased their price target on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research note on Friday, April 5th. Cantor Fitzgerald restated an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research note on Tuesday. Finally, Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Two investment analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Moderate Buy” and a consensus target price of $579.74.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.